{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T03:41:47Z","timestamp":1769571707457,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.schres.2016.04.044","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T09:17:51Z","timestamp":1462958271000},"page":"230-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Gabapentin prevents behavioral changes on the amphetamine-induced animal model of schizophrenia"],"prefix":"10.1016","volume":"175","author":[{"given":"Ana Paula Chiapinotto","family":"Ceretta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa Finger","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catiuscia Molz","family":"de Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeane Binotto","family":"Reinheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Maik\u00e9li","family":"Dotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roselei","family":"Fachinetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.schres.2016.04.044_bb0005","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.biopsych.2004.01.018","article-title":"Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide","volume":"55","author":"Abi-Dargham","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2016.04.044_bb0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4088\/JCP.v60n0408","article-title":"Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: results of an open-label study","volume":"60","author":"Cabras","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2016.04.044_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2011.06.026","article-title":"Effects of antipsychotics and amphetamine on social behaviors in spontaneously hypertensive rats","volume":"225","author":"Calzavara","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.schres.2016.04.044_bb0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00213-015-4118-4","article-title":"Behavioral and neurochemical effects induced by reserpine in mice","volume":"233","author":"de Freitas","year":"2016","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.schres.2016.04.044_bb0025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1059-1311(02)00295-9","article-title":"Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations","volume":"12","author":"Errante","year":"2003","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.schres.2016.04.044_bb0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00702-014-1257-4","article-title":"Effects of diphenyl diselenide on behavioral and biochemical changes induced by amphetamine in mice","volume":"122","author":"Figueira","year":"2014","journal-title":"J Neural Transm (Vienna)"},{"issue":"11","key":"10.1016\/j.schres.2016.04.044_bb0035","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1177\/0269881113503506","article-title":"Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: possible involvement of antioxidant and nitrergic pathways","volume":"27","author":"Monte","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2016.04.044_bb0040","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.neuropharm.2011.01.022","article-title":"GABAergic interneuron origin of schizophrenia pathophysiology","volume":"62","author":"Nakazawa","year":"2012","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.schres.2016.04.044_bb0045","first-page":"133","article-title":"Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms","volume":"55","author":"Pietraszek","year":"2003","journal-title":"Pol. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.schres.2016.04.044_bb0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pharmthera.2006.07.005","article-title":"Novel anticonvulsant drugs","volume":"113","author":"Stefan","year":"2007","journal-title":"Pharmacol. Ther."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416301931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416301931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:25:40Z","timestamp":1536711940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996416301931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":10,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0920996416301931"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2016.04.044","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gabapentin prevents behavioral changes on the amphetamine-induced animal model of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2016.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}